510(k) Report

PMA · Approved

Approved

Elecsys Anti-HCV II Immunoassay, Elecsys Precicontrol Anti-HCV

P140021PMAApproved Jun 11, 2015253-day reviewClass II21 CFR 866.3169

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Operations, Inc. · MZO Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus

Approved on Jun 11, 2015 through premarket approval, which rests on the device’s own clinical evidence after a 253-day review. 1 later device descends from it.

Decided
Jun 11, 2015
Review
253 days
Class
Class II
Product code
MZO
Recalls
None

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2023: 1 descendant cleared201620182020202220242026
  1. This deviceP140021 Elecsys Anti-HCV II Immunoassay, Elecsys Precicontrol Anti-HCVRoche Diagnostics Operations, Inc. · 2015
  2. Descendant · cites it directly · 0 of its ownK221693 Elecsys Anti-HCV II (08837031190)Roche Diagnostics · 2023

Most influential descendants

Showing 1 of 1 · See all
  • K221693Elecsys Anti-HCV II (08837031190)Roche Diagnostics · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)P140021Elecsys Anti-HCV II Immunoassay, Elecsys Precicontrol Anti-HCVRoche Diagnostics Operations, Inc.2015—
+1K221693Elecsys Anti-HCV II (08837031190)Roche Diagnostics2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
FIG. 1 — Lineage of P140021, 2015–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MZO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MZO device

  1. #1 K262156 Anti-HCV Nextscore 12.1 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K221693Elecsys Anti-HCV II (08837031190)Roche Diagnostics20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K221693 (Roche Diagnostics, 2023) has gone furthest, with 0 descendants of its own.

How does its category compare?

All MZO devices

MZO Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · MZO

1in 2023

2007: 52008: 32009: 112010: 122011: 402012: 242013: 162014: 102015: 142016: 192017: 162018: 172019: 112020: 132021: 82023: 12026 (partial year): 2
2007high 40 (2011) · low 0 (2022)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MZO

Too few MZO 510(k)s in any year since 2007 to give a median.

Recalls per year · MZO

1in 2007

2007: 1
2007high 1 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MZO

208in 2025

2007: 202008: 212009: 862010: 512011: 762012: 1362013: 1192014: 572015: 412016: 1152017: 1162018: 1532019: 1382020: 472021: 262022: 562023: 552024: 562025: 208
2007high 208 (2025) · low 20 (2007)2025

MAUDE reports naming product code MZO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20075—120
20083—021
200911—086
201012—051
201140—076
201224—0136
201316—0119
201410—057
201514—041
201619—0115
201716—0116
201817—0153
201911—0138
202013—047
20218—026
20220—056
20231—055
20240—056
20250—0208
20262—0—
Cite this page

510(k) Report. “P140021: Elecsys Anti-HCV II Immunoassay, Elecsys Precicontrol Anti-HCV.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P140021

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026